Dual-Drug Liposomes With YIGSR Peptide Target Breast Tumor Cells in Mice
A YIGSR-modified liposome co-loaded with doxorubicin and 5F showed stronger cytotoxicity, higher cellular uptake and greater tumor accumulation than non-targeted ...
A YIGSR-modified liposome co-loaded with doxorubicin and 5F showed stronger cytotoxicity, higher cellular uptake and greater tumor accumulation than non-targeted ...
A rat study found that ferulic acid loaded into niosomes outperformed the free compound in reducing doxorubicin-induced testicular damage across ...
Adult survivors of high-risk childhood ALL treated with anthracyclines showed a shift over decades from dilated to restrictive-like cardiomyopathy, leaving ...
A mouse study identifies the mitochondrial enzyme CMPK2 as a key mediator of doxorubicin heart injury and reports that flavin ...
A case report describes a 32-year-old man whose lacrimal gland adenoid cystic carcinoma was treated with orbital exenteration and radiotherapy ...
A single gold nanorod platform combining HER2-targeting, NIR imaging, photothermal heating, and doxorubicin delivery eliminated SK-BR-3 breast tumors in mice ...
A new review in Cardio-Oncology outlines how nanoparticle drug delivery systems could reduce doxorubicin-induced cardiotoxicity while preserving antitumor efficacy.
A new cell culture study reports that combining doxorubicin with myo-inositol induced apoptosis in 25.12 percent of MCF7 breast cancer ...
Hyaluronic acid-decorated, iron oxide-loaded PLGA nanoparticles guided by a pulsed electromagnetic field increased tumor accumulation of doxorubicin roughly 1.5-fold in ...
A mouse and cell study finds dexmedetomidine reduces doxorubicin- and trastuzumab-induced myocardial fibrosis by promoting Serpine1 and regulating the STAT3/Notch-1 ...
© 2026 Scienmag - Science Magazine
© 2026 Scienmag - Science Magazine